BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3034288)

  • 1. Modulation of neuronal MAO activity, 5-HT uptake and imipramine binding by endogenous substances in dog cerebrospinal fluid.
    Egashira T; Takano R; Yamanaka Y
    Biochem Pharmacol; 1987 Jun; 36(11):1781-5. PubMed ID: 3034288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MAO activity, 3H-imipramine binding, 3H-paroxetine binding and 3H-5-HT uptake by human cerebrospinal fluid.
    Egashira T; Goto S; Murayama F; Yamanaka Y
    J Neural Transm Suppl; 1990; 32():447-56. PubMed ID: 2150970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of two components of specific [3H]imipramine binding in rat brain.
    Hrdina PD
    Eur J Pharmacol; 1984 Jul; 102(3-4):481-8. PubMed ID: 6092098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5134-8. PubMed ID: 6308674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the existence of serotonin uptake inhibitor-like substances in human cerebrospinal fluid.
    Goto S; Egashira T; Yamanaka Y
    Jpn J Pharmacol; 1991 Jul; 56(3):297-302. PubMed ID: 1832727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The nature of the interactions of imipramine and serotonin with human lymphocytes].
    Lesnichuk SA; Katukov VIu; Porodenko NV
    Eksp Klin Farmakol; 1997; 60(6):40-3. PubMed ID: 9460597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific high affinity [3H]imipramine binding sites in rat lung are associated with a non-neuronal uptake site for serotonin.
    Raisman R; Langer SZ
    Eur J Pharmacol; 1983 Oct; 94(3-4):345-8. PubMed ID: 6317406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H; Fonlupt P; Pacheco H
    C R Seances Soc Biol Fil; 1984; 178(1):38-44. PubMed ID: 6331605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species.
    Egashira T; Takayama F; Yamanaka Y
    Jpn J Pharmacol; 1999 Sep; 81(1):115-21. PubMed ID: 10580379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects.
    Halbreich U; Rojansky N; Zander KJ; Barkai A
    J Psychiatr Res; 1991; 25(1-2):7-18. PubMed ID: 1851224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for high affinity [3H] imipramine binding sites in human lung.
    Morin D; Zini R; Lange J; Tillement JP
    Biochem Biophys Res Commun; 1984 May; 120(3):926-32. PubMed ID: 6329190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The asymmetry of 3H-imipramine binding may predict psychiatric illness.
    Demeter E; Tekes K; Majorossy K; Palkovits M; Soós M; Magyar K; Somogyi E
    Life Sci; 1989; 44(19):1403-10. PubMed ID: 2541295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative autoradiography of [3H]nitroimipramine binding sites in rat brain.
    Rainbow TC; Biegon A
    Brain Res; 1983 Mar; 262(2):319-22. PubMed ID: 6301637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.